It's a mix. When biotech companies get the R and D credits, when they come back, they will come to the company. But the company will either spend it directly within its own staffing or will invest it back into the research institutions, whether it be outsourcing to NRC, to academic labs, or to other partners. Any money that comes back from an R and D refundable credit is 100% spent, again, in terms of research dollars.
